Bicara Therapeutics BCAX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's prepaid & other current?
- Bicara Therapeutics (BCAX) reported prepaid & other current of $5.16M in Q1 2026.
- How has Bicara Therapeutics's prepaid & other current changed year-over-year?
- Bicara Therapeutics's prepaid & other current decreased by 40.6% year-over-year, from $8.69M to $5.16M.
- What is the long-term trend for Bicara Therapeutics's prepaid & other current?
- Over 2 years (2023 to 2025), Bicara Therapeutics's prepaid & other current has grown at a 238.5% compound annual growth rate (CAGR), from $633K to $7.25M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.